Innovation Fund | Brussels

Innovation Fund | Brussels specializes in providing strategic capital to emerging ventures within the chemistry and life sciences sectors. With a dedicated focus on breakthrough technologies and scientific advancements, the fund identifies and supports companies with transformative potential. Their investment approach emphasizes both financial returns and positive industry impact through sustainable innovation. The fund maintains a particular interest in solutions addressing global challenges in healthcare, materials science, and environmental sustainability.

Established by leading industry partners and financial institutions, Innovation Fund brings together extensive technical expertise and market knowledge to evaluate complex scientific ventures. Their investment team combines backgrounds in chemistry, biotechnology, pharmaceutical development, and venture capital, enabling thorough assessment of both scientific merit and commercial viability. This multidisciplinary approach allows them to identify promising technologies at earlier stages than generalist investors, often becoming the first institutional investor in high-potential scientific startups across Europe.

The fund typically engages with companies from seed to Series B stages, with initial investments ranging from €250,000 to €2 million and capacity for follow-on participation. Their portfolio encompasses diverse subsectors including biopharmaceuticals, advanced materials, green chemistry, medical devices, and agricultural technology. Innovation Fund provides more than just capital, offering portfolio companies access to an extensive network of industry connections, scientific advisors, and potential commercial partners. This value-added approach has contributed to their strong track record of accelerating scientific commercialization and supporting companies through regulatory pathways.

Beyond financial objectives, Innovation Fund demonstrates commitment to advancing scientific progress and sustainable development. They actively promote collaboration between academic institutions, research centers, and industry partners to bridge the gap between laboratory discoveries and market applications. The fund maintains a long-term investment horizon, recognizing that scientific ventures often require extended development timelines. Their patient capital approach, combined with hands-on strategic guidance, has established Innovation Fund as a trusted partner for scientist-entrepreneurs navigating the complex journey from breakthrough discovery to commercial success.